--Southwest Airlines Keeps Quarterly Dividend at $0.18 per Share, Payable July 10 to Shareholders of Record June 19-February 2024-www.financetom.com

--Southwest Airlines Keeps Quarterly Dividend at $0.18 per Share, Payable July 10 to Shareholders of Record June 19

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Southwest Airlines Keeps Quarterly Dividend at $0.18 per Share, Payable July 10 to Shareholders of Record June 19

May 15, 2024 8:07 AM

10:37 AM EDT, 05/15/2024 (MT Newswires) --

Price: 27.77, Change: -0.36, Percent Change: -1.28

Previous page： UroGen Pharma Says US FDA Accepts New Drug Application for Bladder Cancer Treatment Next page： BRIEF-Point72 Asset Management, L.P. Reports 6.2% Passive Stake In ATYR Pharma As Of Oct 14 - SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

UroGen Pharma Says US FDA Accepts New Drug Application for Bladder Cancer Treatment

Oct 17, 2024

05:04 PM EDT, 10/15/2024 (MT Newswires) -- UroGen Pharma ( URGN ) said Tuesday the US Food and Drug Administration accepted the new drug application for UGN-102 as an intravesical solution to treat low-grade intermediate-risk non-muscle invasive bladder cancer. The FDA has set a Prescription Drug User Fee Act target action date of June 13, 2025, the company said. The...

BRIEF-Point72 Asset Management, L.P. Reports 6.2% Passive Stake In ATYR Pharma As Of Oct 14 - SEC Filing

Oct 17, 2024

Oct 15 (Reuters) - aTyr Pharma Inc ( ATYR ): * POINT72 ASSET MANAGEMENT, L.P. REPORTS 6.2% PASSIVE STAKE IN ATYR PHARMA AS OF OCT 14 - SEC FILING Source text for Eikon: Further company coverage: ...

NovoCure Says US FDA Approves Optune Lua to Treat Lung Cancer; Shares Jump After Hours

Oct 17, 2024

05:05 PM EDT, 10/15/2024 (MT Newswires) -- NovoCure ( NVCR ) said late Tuesday the US Food and Drug Administration has approved its Optune Lua device to treat adults with metastatic non-small cell lung cancer. The approval is for the simultaneous use of Optune Lua with PD-1/PD-L1 inhibitors or docetaxel in lung cancer patients who have progressed on or after...

New York Bancorp changes name to Flagstar Financial

Oct 17, 2024

Oct 15 (Reuters) - New York Community Bancorp ( NYCB/PA ) said on Tuesday it has changed its name to Flagstar Financial and its stock symbol to FLG. ...